Loveland B - Search Results

1

Vaccination with in vitro grown whole tumor cells induces strong immune responses and retards tumor growth in a murine model of colorectal liver metastases.

Fifis T, Lam I, Lin D, Malcontenti-Wilson C, Christophi C, Loveland B. Fifis T, et al. Among authors: loveland b. Vaccine. 2008 Jan 10;26(2):241-9. doi: 10.1016/j.vaccine.2007.10.068. Epub 2007 Nov 21. Vaccine. 2008. PMID: 18069095

2

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.

Apostolopoulos V, Pouniotis DS, van Maanen PJ, Andriessen RW, Lodding J, Xing PX, McKenzie IF, Loveland BE, Pietersz GA. Apostolopoulos V, et al. Vaccine. 2006 Apr 12;24(16):3191-202. doi: 10.1016/j.vaccine.2006.01.032. Epub 2006 Jan 25. Vaccine. 2006. PMID: 16480791

3

Dendritic cell vaccination.

Proudfoot O, Pouniotis D, Sheng KC, Loveland BE, Pietersz GA. Proudfoot O, et al. Expert Rev Vaccines. 2007 Aug;6(4):617-33. doi: 10.1586/14760584.6.4.617. Expert Rev Vaccines. 2007. PMID: 17669014 Review.

4

Update on Mucin-1 immunotherapy in cancer: a clinical perspective.

Rivalland G, Loveland B, Mitchell P. Rivalland G, et al. Among authors: loveland b. Expert Opin Biol Ther. 2015;15(12):1773-87. doi: 10.1517/14712598.2015.1088519. Epub 2015 Oct 9. Expert Opin Biol Ther. 2015. PMID: 26453294 Review.

5

Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.

Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL. Loveland BE, et al. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):869-77. doi: 10.1158/1078-0432.CCR-05-1574. Clin Cancer Res. 2006. PMID: 16467101 Clinical Trial.

6

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF. Apostolopoulos V, et al. Among authors: loveland be. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10128-32. doi: 10.1073/pnas.92.22.10128. Proc Natl Acad Sci U S A. 1995. PMID: 7479739 Free PMC article.

7

Aspects of cancer immunotherapy.

McKenzie IF, Apostolopoulos V, Plebanski M, Pietersz GA, Loveland BE. McKenzie IF, et al. Immunol Cell Biol. 2003 Feb;81(1):79-85. doi: 10.1046/j.0818-9641.2002.01140.x. Immunol Cell Biol. 2003. PMID: 12534951

8

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Drakaki H, Loveland BE, Piddlesden SJ, Plebanski M, Pouniotis DS, Alexis MN, McKenzie IF, Vassilaros S. Apostolopoulos V, et al. Breast Cancer Res. 2006;8(3):R27. doi: 10.1186/bcr1505. Epub 2006 Jun 15. Breast Cancer Res. 2006. PMID: 16776849 Free PMC article. Clinical Trial.

9

Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII.

Lanteri MB, Powell MS, Christiansen D, Li YQ, Hogarth M, Sandrin MS, Mckenzie IF, Loveland BE. Lanteri MB, et al. Among authors: loveland be. Transplantation. 2000 Mar 27;69(6):1128-36. doi: 10.1097/00007890-200003270-00018. Transplantation. 2000. PMID: 10762218

10

CD46 protects pig islets from antibody but not cell-mediated destruction in the mouse.

McKenzie IF, Li YQ, Xing PX, Dinatale I, Koulmanda M, Loveland BE, Sandrin MS. McKenzie IF, et al. Xenotransplantation. 2003 Nov;10(6):615-21. doi: 10.1034/j.1399-3089.2003.00066.x. Xenotransplantation. 2003. PMID: 14708531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page